Richard Klausner
CIK 1591178 · Executive Chairman · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.13M
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$11.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLS | Director | — | — | — | $0 | 1 | 2026-06-11 |
| LYEL | Director | 3,811,199 | $13.50 | $51.45M | -$108.4K | 9 | 2025-05-19 |
| Juno Therapeutics, Inc. (JUNO) Delisted | Director | 0 | — | — | -$10.49M | 27 | 2018-03-07 |
| ILMN | Sr VP, Chief Medical Officer | 22,847 | $160.97 | $3.68M | -$420.0K | 10 | 2016-02-01 |
Recent Filings · Page 2 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −728,775 | -$61.38M | EDGAR |
| 2018-01-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −12,476 | -$613.4K | EDGAR |
| 2017-12-22 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −36,000 | -$1.61M | EDGAR |
| 2017-10-06 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +266 | $0 | EDGAR |
| 2017-09-08 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −12,000 | -$511.9K | EDGAR |
| 2017-08-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −12,000 | -$364.1K | EDGAR |
| 2017-07-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −23,620 | -$705.3K | EDGAR |
| 2017-06-19 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −24,000 | -$566.4K | EDGAR |
| 2017-04-06 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +514 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.